ANI Pharmaceuticals Inc — Liquidità (NASDAQ:ANIP) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative 15.27 M3.32 M-31.2 M118.96 M64.02 M185.22 M 185.22 M Flussi di cassa derivanti dalle attività di investimento -68.32 M-105.48 M-15.74 M-18.51 M-404.72 M-34.32 M -34.32 M Liquidità derivante dalle attività di finanziamento -1.44 M194.59 M-5.13 M67.44 M264.94 M-9.94 M -9.94 M Liquidità libera -53.05 M-20.32 M-47.66 M100.45 M47.06 M150.9 M 150.9 M

Notizie

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data

ANI Pharmaceuticals lancia capsule generiche di carbamazepina

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

ANI Pharmaceuticals Stock: Undervalued Cortrophin Drives Rare Disease Growth (NASDAQ:ANIP)

Zacks.com featured highlights include Intuit, ANI Pharmaceuticals and Gaming and Leisure Properties

Is American Well (AMWL) Outperforming Other Medical Stocks This Year?

Insmed Ends Brinsupri Development in Skin Disease Post Study Failure

ANI Pharmaceuticals lancia le compresse generiche di isosorbide mononitrato

ANI Pharmaceuticals Stock: Worthy Of A Position (NASDAQ:ANIP)

Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus

AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD